A Heavy Burden

Area of Science:

• Public Health
• Health Economics
• Maternal and Child Health

Background:

• Gestational diabetes mellitus (GDM) and maternal obesity are significant public health concerns.
• These conditions pose a substantial financial burden on healthcare systems, particularly state Medicaid programs.

Purpose of the Study:

• To quantify the excess medical and drug costs associated with GDM and pregestational diabetes in pregnant women enrolled in Texas Medicaid.
• To assess the financial impact of maternal obesity on the same population.

Main Methods:

• Analysis of Texas Medicaid data to determine cost differences.
• Comparison of healthcare expenditures between women with diabetes/obesity and a control group of non-diabetic, normal-weight women.

Main Results:

• Women with GDM and their infants incurred $10 million in excess medical and drug costs within the Medicaid program.
• Women with pregestational diabetes incurred $60 million more in costs compared to non-diabetic, normal-weight women.
• Increased hospitalizations for mothers and higher rates of neonatal intensive care unit admissions for infants contributed significantly to these costs.

Conclusions:

• Maternal diabetes and obesity represent a major financial strain on the Texas Medicaid program.
• Targeted interventions and management strategies for GDM and obesity in pregnant women could lead to significant cost savings.
• Addressing these maternal health issues is crucial for improving both patient outcomes and healthcare system sustainability.